Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Silicon Motion Technology Corporation American Depositary Shares (SIMO) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

Silicon Motion Technology Corporation American Depositary SharesTrade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

Silicon Motion Technology Corporation American Depositary Shares vs Zimmer Biomet Holdings Inc — how do they compare? Silicon Motion Technology Corporation American Depositary Shares trades at $221 (market cap $8.36B), while Zimmer Biomet Holdings Inc trades at $92.24 (market cap $17.56B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 2.1× Silicon Motion Technology Corporation American Depositary Shares's market cap, and Zimmer Biomet Holdings Inc pays the higher dividend (1.04%). Which is the better fit depends on your goals — on Pluang, investors hold Silicon Motion Technology Corporation American Depositary Shares for 0 Days and Zimmer Biomet Holdings Inc for 89 Days on average.

SIMOZBH
Market Cap
$8.36B$17.56B
Volume
663,6822,298,426
Sector
TechnologyHealth
52-Week High
$336.90$103.98
52-Week Low
$80.16$79.58
Typical Hold Time
0 Days89 Days
Enterprise Value
$8.35B$24.63B
Dividend Yield
0.81%1.04%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Silicon Motion Technology Corporation American Depositary Shares

Silicon Motion (SIMO) trades at $246.63, down 0.13% on the day, with technical indicators showing neutral signals. The company demonstrates strong fundamentals with Q2 2026 EPS beating expectations at $2.43 versus $2.13, and revenue growth projected to reach $1.3B in 2026. Analyst sentiment remains overwhelmingly positive with 81% buy ratings and a consensus price target of $356.25, representing 44% upside potential from current levels.

The outlook for SIMO appears favorable given accelerating enterprise storage demand and AI infrastructure expansion. Key risks include semiconductor cycle volatility and competitive pressures in NAND controllers. With robust profitability metrics including 31.6% ROE and expanding margins, the stock offers growth exposure to the AI storage market, though investors should monitor execution on Q3 2026 earnings expectations of $3.3 EPS.

Zimmer Biomet Holdings Inc

Zimmer Biomet (ZBH) trades at $91.77, down 0.43% on the day, with a bullish technical signal supported by moving averages. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $2.07 exceeding expectations. Revenue growth remains steady at $8.23B for 2025, though net income margins have moderated from 13.84% in 2023 to 8.56% in 2025. The company maintains strong profitability with a 69.87% gross margin and recently announced a $0.24 quarterly dividend.

ZBH presents a mixed outlook with positive earnings momentum and analyst consensus price target of $103.11 offering 12% upside potential. However, rising debt levels and competitive pressures in medical technology pose risks. Institutional ownership trends show continued interest, with State Street increasing its position by 0.6% in Q3 2026. The stock's valuation at 22.35 P/E appears reasonable given the company's market leadership position.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SIMO
100% Buy0% Sell
Avg holding period · 0 Days
ZBH

No sentiment data available yet.

Top news

Latest headlines on both assets

About Silicon Motion Technology Corporation American Depositary Shares

Silicon Motion Technology Corporation designs and develops NAND flash controllers for solid-state storage, with flagship SSD, eMMC, and UFS controller products, including its Ferri-branded automotive and industrial storage solutions, used by OEMs and NAND flash makers worldwide.

Read more on SIMO →

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH →